Phase I study on docetaxel and ifosfamide in patients with advanced solid tumours.

Docetaxel and ifosfamide have shown significant activity against a variety of solid tumours. This prompted a phase I trial on the combination of these drugs. This phase I study was performed to assess the feasibility of the combination, to determine the maximum tolerated dose (MTD) and the side effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Pronk, L. C., Schrijvers, D., Schellens, J. H., de Bruijn, E. A., Planting, A. S., Locci-Tonelli, D., Groult, V., Verweij, J., van Oosterom, A. T.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1998
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2151260/
https://www.ncbi.nlm.nih.gov/pubmed/9459161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2151260/
https://www.ncbi.nlm.nih.gov/pubmed/9459161

Ejemplares similares